Published in Lancet on August 06, 1983
Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.21
Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. J Pediatr (1998) 2.02
First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ (1992) 1.95
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem (1997) 1.68
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem (1997) 1.67
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis (2008) 1.55
Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation (2000) 1.49
Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. Eur J Biochem (1994) 1.49
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods (1981) 1.46
Focal necrotic hepatitis in mice as a biological marker for differentiation of Herpesvirus hominis type 1 and type 2. J Gen Virol (1974) 1.43
Immunohistochemical localization of two endometrial proteins in the early days of human pregnancy. Placenta (1994) 1.40
Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest (2001) 1.33
Pregnancy-associated plasma protein A: circulating levels during normal pregnancy. Am J Obstet Gynecol (1981) 1.33
Dlk1 in normal and abnormal hematopoiesis. Leukemia (2005) 1.28
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem (1999) 1.28
Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods Enzymol (1981) 1.26
Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest (2002) 1.15
Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology (2001) 1.14
Two pregnancy-associated serum proteins with pregnancy-specific beta1-glycoprotein determinants. Am J Obstet Gynecol (1978) 1.09
Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation. Mol Endocrinol (1998) 1.08
Studies on the isolation, structural analysis and tissue localization of fetal antigen 1 and its relation to a human adrenal-specific cDNA, pG2. Hum Reprod (1993) 1.05
Typologies of caregiving families: family congruence and individual well-being. Gerontologist (1997) 1.05
Humoral immunity to dietary antigens in healthy adults. Occurrence, isotype and IgG subclass distribution of serum antibodies to protein antigens. Int Arch Allergy Appl Immunol (1985) 1.05
Mouse fetal antigen 1 (mFA1), the circulating gene product of mdlk, pref-1 and SCP-1: isolation, characterization and biology. J Reprod Fertil (1996) 1.04
Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus: a prospective, controlled study. Andrology (2013) 1.04
Factor I deficiency and C3 nephritic factor: immunochemical findings and association with Neisseria meningitidis infection in two patients. Scand J Immunol (1984) 1.04
International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem (1995) 1.03
Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol (2008) 1.03
Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. Mol Hum Reprod (2000) 1.02
Severe dermatomyositis treated with cyclosporin A. Ann Rheum Dis (1986) 1.02
FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression. Histochem Cell Biol (1996) 1.01
Purification and characterization of a bovine serum lectin (CL-43) with structural homology to conglutinin and SP-D and carbohydrate specificity similar to mannan-binding protein. J Biol Chem (1993) 1.01
Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem (1995) 0.98
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer. Pharmacogenomics J (2010) 0.97
Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg (1987) 0.96
Immunosuppressive effect of human pregnancy zone protein on H-2 incompatible mouse heart allografts. Acta Pathol Microbiol Scand C (1978) 0.96
Specific assay for pregnancy-specific-beta 1-glycoprotein (Sp1-beta). Preparation of antiserum specific for SP1-beta by absorption with a crossreacting high molecular weight serum protein. J Reprod Immunol (1979) 0.95
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer. Int J Gynecol Cancer (2007) 0.95
Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol (1993) 0.94
Circulating C3, C4, and C3 split products (C3c and C3d) during normal pregnancy. Am J Reprod Immunol (1982) 0.94
Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk. Neuroreport (2001) 0.94
Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c. Immunology (1994) 0.93
Understanding the well-being of care receivers. Gerontologist (1997) 0.92
Screening for methicillin-resistant Staphylococcus aureus in clinical swabs using a high-throughput real-time PCR-based method. Clin Microbiol Infect (2007) 0.92
Microfibril-associated protein 4 is present in lung washings and binds to the collagen region of lung surfactant protein D. J Biol Chem (1999) 0.92
Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation. J Clin Lab Immunol (1983) 0.92
Expression, biosynthesis and release of preadipocyte factor-1/ delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications. J Endocrinol (2003) 0.91
Increased number of IgG Fc receptors on monocyte-enriched peripheral blood leucocytes from patients with rheumatoid arthritis. Scand J Immunol (1982) 0.91
Oxygen affinity of haemoglobin and red cell 2,3-diphosphoglycerate in childhood diabetes. Acta Paediatr Scand (1975) 0.91
The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer. Int J Gynecol Cancer (2007) 0.91
Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest (2001) 0.90
Pregnancy-associated plasma protein A: a possible marker in the classification and prenatal diagnosis of Cornelia de Lange syndrome. Prenat Diagn (1983) 0.90
Purification and characterization of bovine mannan-binding protein. Glycobiology (1993) 0.89
Two fetal antigens (FA-1 and FA-2) and endometrial proteins (PP12 and PP14) isolated from amniotic fluid; preliminary observations in fetal and maternal tissues. Eur J Obstet Gynecol Reprod Biol (1988) 0.89
Circulating levels of pregnancy zone protein: normal range and the influence of age and gender. Clin Chim Acta (1981) 0.89
Collagen-derived markers of bone metabolism in osteogenesis imperfecta. Acta Paediatr (1998) 0.89
Circadian and diurnal variation of circulating immune complexes, complement-mediated solubilization, and the complement split product C3d in rheumatoid arthritis. Scand J Rheumatol (1986) 0.88
Separation of human peripheral blood monocytes on continuous density gradients of polyvinylpyrrolidone-coated silica gel (Percoll). J Immunol Methods (1982) 0.88
Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease. Acta Med Scand (1988) 0.88
Quantitation of circulating immune complexes by combined PEG precipitation and immunoglobulin-specific radioimmunoassay (PICRIA). Methods Enzymol (1981) 0.88
Interaction between heparin and human pregnancy-associated plasma protein A (PAPP-A): a simple purification procedure. Anal Biochem (1983) 0.88
Tissue localization of conglutinin, a bovine C-type lectin. Immunology (1992) 0.88
S and Z alpha1-antitrypsin alleles are risk factors for bronchial hyperresponsiveness in young farmers: an example of gene/environment interaction. Eur Respir J (2000) 0.88
Fetal antigen 1 (FA1), a circulating member of the epidermal growth factor (EGF) superfamily: ELISA development, physiology and metabolism in relation to renal function. Clin Chim Acta (1997) 0.88
Purification and characterization of mannan-binding protein from mouse serum. Scand J Immunol (1994) 0.88
Pregnancy-associated plasma protein A in the prediction of early pregnancy failure. Am J Obstet Gynecol (1983) 0.88
C-reactive protein in general practice--how commonly is it used and why? Scand J Prim Health Care (1997) 0.87
Radioimmunoassay for pregnancy-associated plasma protein A. Clin Chem (1982) 0.87
Screening for complement deficiencies in unselected patients with meningitis. Clin Exp Immunol (1987) 0.87
Fetal antigen 1, an EGF multidomain protein in the sex hormone-producing cells of the gonads and the microenvironment of germ cells. Mol Hum Reprod (1999) 0.87
Studies of pregnancy-associated murine serum proteins. J Reprod Fertil (1978) 0.87
Immunohistochemical demonstration of pregnancy-associated plasma protein A (PAPP-A) in the syncytiotrophoblast of the normal placenta at different gestational ages. Placenta (1985) 0.87
Histochemistry and acetylcholine receptor distribution in normal and denervated monkey extraocular muscles. Neurology (1978) 0.87
Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol (2007) 0.86
Pregnancy associated plasma protein-A: interaction with heparin in crossed affinity immunoelectrophoresis. Aust N Z J Med (1981) 0.86
Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. J Clin Endocrinol Metab (2001) 0.86
Specific and reversible interaction between pregnancy-associated plasma protein A and heparin. Placenta (1983) 0.86
Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand J Rheumatol (1992) 0.86
Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d. Scand J Clin Lab Invest Suppl (1984) 0.86
Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with IBD. Gut (2000) 0.86
A family with complement factor I deficiency. Scand J Immunol (1986) 0.86
Immunochemical and biological studies on two molecular variants of pregnancy specific beta 1 glycoprotein (SP1) SP1 alpha and SP1 beta. Clin Chim Acta (1980) 0.86
The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab. Gynecol Oncol (2010) 0.85
C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections. Acta Pathol Microbiol Immunol Scand C (1984) 0.85
The effect on pregnancy of intrauterine administration of antibodies against two pregnancy-associated murine proteins: murine pregnancy-specific beta 1-glycoprotein and murine pregnancy-associated alpha 2-glycoprotein. Biomed Biochim Acta (1985) 0.85
Measurement of glucose content in plasma from capillary blood in diagnosis of diabetes mellitus. Scand J Clin Lab Invest (2003) 0.85
Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis (1997) 0.85
Three cases of factor I deficiency: the effect of treatment with plasma. Clin Exp Immunol (1988) 0.85
Fetal antigen 1 and growth hormone in pituitary somatotroph cells. Lancet (1996) 0.85